Scott Gottlieb, MD

Scott Gottlieb, MD, served as the 23rd Commissioner of the U.S. Food and Drug Administration and is currently a partner at the venture capital firm New Enterprise Associates, where he led the firm’s investments in National Resilience and Comanche Biopharma, and serves on the boards of directors. He is also a member of the board of directors of Pfizer Inc, Illumina Inc, Tempus AI, and Aetion, Inc. Dr. Gottlieb is a senior fellow at the public policy think tank the American Enterprise Institute and previously served as the FDA’s deputy commissioner and before that, as a senior adviser to the Administrator of the Centers for Medicare and Medicaid Services. He is the author of the New York Times bestselling book “Uncontrolled Spread: Why Covid-19 Crushed Us, and How We Can Defeat the Next Pandemic,” and is a contributor to CNBC and CBS News’ Face the Nation. Dr. Gottlieb completed medical school and residency in internal medicine at the Mount Sinai School of Medicine and is an elected member of the National Academy of Medicine. He graduated from Wesleyan University, where he majored in economics, and serves on the boards of directors of Wesleyan University and the Mount Sinai Health System.